Breast Lesion Localization Methods Market By Type (Wire, Radioisotope [Radio Occult], Magnetic), Usage (Tumor Identification, Sentinel Lymph Node [Lumpectomy]), End-User Preference Survey (Selection Criteria, Replacement Trend) – Global Forecast to 2025

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=530937

Some of the key players in the breast lesion localization methods market are Hologic Inc. (US), Laurane Medical (US), Mermaid Medical A/S (Denmark), IZI Medical Products (US), Matek Medical Inc. (Turkey), Tsunami Medical Inc. (Italy), BPB Medica (Italy), Sirius Medical BV (Netherlands), Molli Surgical Inc. (Canada), Argon Medical Devices (US), B.D. Company (US), Cianna Medical (US), Endomagnetics Ltd. (UK), Health Beacons, Inc. (Australia), Intra-Medical Imaging LLC (US), IsoAid, LLC (US), Leica Biosystems (Germany), SOMATEX Medical Technologies GmbH (Germany), SurgicEye GmbH (Germany) and Ranfac Corporation ((US). The study includes an in-depth competitive analysis of these key players in the breast lesion localization methods market, along with their company profiles, recent developments, and key market strategies.

The world-class Breast Lesion Localization Methods Market report includes a range of inhibitors as well as driving forces of the market which are analyzed in both qualitative and quantitative approach so that readers and users get precise information and insights about the industry. With the meticulous competitor analysis covered in this report, businesses can gauge or analyze the strengths and weak points of the competitors which helps build superior business strategies for their own product. To gain actionable market insights to build sustainable and money-spinning business strategies with ease, the Breast Lesion Localization Methods Market research report is a great option.

The breast lesion localization methods market is expected to grow at a CAGR of 7.5% in the forecast period.

Market for breast lesion localization methods is expected to grow from 3,974.4 thousands of procedures in 2020 to 5750.9 thousands of procedures by 2025, at a CAGR of 7.5% during the forecast period. The breast lesion localization methods market is driven primarily by the increasing incidence of breast cancer, rising number of breast cancer surgeries, and growing awareness on the early detection of breast cancer. However, uncertainty in regulatory approval procedures is expected to restrain the growth of this market during the forecast period.

The Covid-19 pandemic has largely impacted healthcare delivery globally since December 2019. Non-essential procedures related to breast cancer care and routine breast screening programs have been postponed in many countries as healthcare resources are diverted to handle the pandemic crisis. The selection of the type of breast lesion localization method in the current scenario and in the post lockdown period can be considered from three aspects: time taken for procedure, re-operation/re-excision rates and cost of the breast lesion localization device.

Revised guidelines for breast cancer care have been suggested by cancer organizations and oncologists in most regions, most of which focus on minimizing outpatient and inpatient admissions and staggering schedules to reduce patient influx daily. The time taken for the procedure becomes crucial in this scenario for the convenience of patients and healthcare providers and also to lower the chances of spread of viral infection. In this case, healthcare providers may not favor wire guided localization (WGL) procedures as they require almost twice as much time as other procedures. Moreover, the chances of re-excision in case of this procedure is also high.

“The wire localization segment held the largest share of the breast lesion localization methods market in 2020.”

Based on type, the breast lesion localization methods market is divided into five major segments—wire localization, isotope localization, magnetic localization, electromagnetic localization, and others. The wire localization segment accounted for the largest share of the breast lesion localization methods market in 2020. The large share of this segment is attributed to its accuracy in abnormal tissue localization, minimum removal of normal tissues, minimal scarring, and the availability of reimbursement for breast lesion localization devices.

“Asia Pacific accounted the largest share and is projected to grow at the highest CAGR during the forecast period.”

The Asia Pacific accounted the largest share and is projected to record the highest growth in the breast lesion localization methods market during the forecast period. The rapidly increasing patient population, increasing healthcare expenditure, improving healthcare infrastructure, high government spending on breast cancer research, and increasing awareness are the major factors supporting the growth of the Asia Pacific breast lesion localization methods market.

The report also contains a detailed analysis of end-user preference for the adoption of different breast lesion localization methods. The research findings cited in the report encapsulates the important selection criteria for breast lesion localization methods from an end-user point of view. It analyses importance given to the particular criteria while selecting a breast lesion localization methods. Important criteria for the selection of breast lesion localization methods include detection and success rate, re-excision rate, cost, mean localization time, effectiveness, safety, and ease of use.

In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the breast lesion localization method market.

By Company: Tier 1: 60%, Tier 2: 30%, and Tier 3: 10%
By Designation: C-level Executives: 47%, Directors: 33%, and Others: 20%
By Region: North America: 57%, Europe: 26%, APAC: 9%, and the RoW: 8%
Research Coverage:

The market study covers the breast lesion localization methods market across various segments. It aims at estimating the market size (in terms of volume) and the growth potential of this market across different segments by type, usage, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of breast lesion localization procedures market and its sub-segments. This report will help stakeholders to understand the competitive landscape, gain insights to better position their businesses, and plan suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.

For More Information or Query or Customization Before Buying, Visit @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=530937

Table of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Category-Wise Inclusions And Exclusions In The Breast Lesion Localization Market
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered For The Study
1.4 Currency
Table 1 Standard Currency Conversion Rate
1.5 Limitations
1.6 Stakeholders
1.7 Summary Of Changes

2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
Figure 2 Primary Sources For The Breast Lesion Localization Methods Market
2.1.2.1 Key Data From Primary Sources
Figure 3 Breakdown Of Primaries: Global Breast Lesion Localization Methods Market
2.2 Market Size Estimation
2.2.1 Market Sizing Approach For The Breast Lesion Localization Methods Market: Demand-Side Approach (Approach 1)
Figure 4 Market Size Estimation: Demand-Side Approach (Approach 1)
2.2.2 Market Sizing Approach For The Breast Lesion Localization Methods Market: Demand-Side (Approach 2)
Figure 5 Market Size Estimation: Demand-Side Approach (Approach 2)
Figure 6 Market Size Estimation: Demand-Side Approach (Approach 3)
2.3 Market Breakdown And Data Triangulation
Figure 7 Data Triangulation Methodology
2.3.1 Assumptions

3 Executive Summary
Figure 8 Breast Lesion Localization Methods Market, By Type,2020 Vs. 2025 (Thousand Procedures)
Figure 9 Radioisotope Localization Methods Market, By Type,2020 Vs. 2025 (Thousand Procedures)
Figure 10 Breast Lesion Localization Methods Market, By Usage,2020 Vs. 2025 (Thousand Procedures)
Figure 11 Geographic Snapshot: Breast Lesion Localization Methods Market

4 Premium Insights
4.1 Breast Lesion Localization Methods Market Overview
Figure 12 Rising Awareness Is Expected To Drive Market Growth
4.2 Asia Pacific: Breast Lesion Localization Methods Market, 2019
Figure 13 Wire Localization Held The Largest Share Of The Asia Pacific Breast Lesion Localization Methods Market In 2019
4.3 Breast Lesion Localization Methods Market: Geographic Mix
Figure 14 Asia Pacific Will Continue To Dominate The Breast Lesion Localization Methods Market Till 2025

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 15 Breast Lesion Localization Methods Market: Drivers, Restraints, Opportunities, And Challenges
5.3 Drivers
5.3.1 Growing Incidence Of Breast Cancer
Table 2 Top 10 Countries With The Highest Incidence Of Breast Cancer, 2018
Figure 16 Incidence Of Breast Cancer (Million Cases) From 2012–2025
5.3.2 Increasing Number Of Breast Cancer Surgeries
Figure 17 Estimated Number Of Breast Cancer Surgeries (Million Cases) From 2012–2024
5.3.3 Increasing Awareness On The Early Detection Of Breast Cancer
5.4 Restraints
5.4.1 Uncertainty In Regulatory Approval Procedures
5.5 Opportunities
5.5.1 Emerging Economies Offer High Growth Potential
5.5.2 Increasing Adoption Of Technologically Advanced Localization Procedures
5.6 Challenges
5.6.1 Shortage Of Oncologists
5.7 Impact Of Covid-19 On The Breast Lesion Localization Market: Restructuring Of Breast Cancer Care
5.8 Adjacent Market Tables

6 Industry Insights
6.1 Industry Trends
6.1.1 Electromagnetic Waves For Localization Of Breast Lesions
6.1.2 Radiofrequency Identification In Breast Lesion Localization
6.1.3 Machine Learning Algorithms For Computer-Aided Breast Lesion Detection
6.1.4 Reimbursement Guidelines For Breast Lesion Localization Device Placement
Figure 18 Codes, Definitions, & Physician Payment For Breast Lesion Localization Procedures (Medicare & Medicaid Services – Hopps)
Figure 19 Reimbursement For Breast Lesion Localization Device Placement, 2014–2018

Read More…………………..